Ignite Creation Date:
2024-05-06 @ 12:47 AM
Last Modification Date:
2024-10-26 @ 10:54 AM
Study NCT ID:
NCT01658462
Status:
COMPLETED
Last Update Posted:
2019-05-31
First Post:
2012-07-31
Brief Title:
Phase II Study of Docetaxel - Nintedanib in Breast Cancer
Sponsor:
Centre Oscar Lambret
Organization:
Centre Oscar Lambret
Organization Data
Organization:
Centre Oscar Lambret
Class:
OTHER
Study ID:
VAROCE - 1206
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Centre Oscar Lambret
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Boehringer Ingelheim | INDUSTRY |